YouTube is conducting a “voluntary exit program” with severance for U.S.-based employees, the company confirmed to TechCrunch on Wednesday. The news was first reported by Sources. YouTube CEO Neal Mohan told employees about the program via an internal memo on Wednesday. The memo also announced that the Google-owned company was reorganizing its product teams into three separate organizations that all …
Read More »
Foodynamics and Raw Bistro are recalling several of their pet food brands over possible salmonella contamination. Salmonella can affect animals as well as humans handling contaminated pet products, especially if they have not thoroughly washed their hands after contact with the products or any surfaces exposed to the products. Foodynamics is recalling specific lots of Raw Dog Barkery, Bellepepper Cats, …
Read More »
Keep up with LAist. If you’re enjoying this article, you’ll love our daily newsletter, The LA Report. Each weekday, catch up on the 5 most pressing stories to start your morning in 3 minutes or less. The Department of Homeland Security has begun targeting unaccompanied children in the immigration system with what they call a “voluntary option” to return to …
Read More »
For Immediate Release: July 28, 2025 The U.S. Food and Drug Administration is recommending the removal of the voluntary hold for ambulatory patients who may now receive Elevidys, a Sarepta Therapeutics gene therapy for Duchenne Muscular Dystrophy (DMD). The FDA’s investigation has concluded that the death of the 8-year-old boy is unrelated to the gene therapy product itself . …
Read More »Sarepta Therapeutics Announces Voluntary Pause of ELEVIDYS Shipments in the U.S. Sarepta Therapeutics In surprise reversal, Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy statnews.com Sarepta LGMD trials all hit by FDA hold amid newly surfaced safety concerns over gene therapy Fierce Biotech Sarepta shares plunge 40% as future of its gene therapy appears at risk CNBC Sarepta Therapeutics stock sinks …
Read More »
Meta says it won’t sign the European Union’s artificial intelligence code of practice agreement, warning that “Europe is heading down the wrong path on AI.” The code published by the EU on July 10th is a voluntary set of guidelines to help companies follow the AI Act’s rules around general-purpose AI before they come into effect in a few weeks. …
Read More »